BEATOLIN ELIXIR 2MG5ML

Country: Malaysia

Bahasa: Inggeris

Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Bahan aktif:

SALBUTAMOL SULPHATE

Boleh didapati daripada:

Duopharma Marketing Sdn. Bhd.

INN (Nama Antarabangsa):

SALBUTAMOL SULPHATE

Unit dalam pakej:

100ml mL

Dikeluarkan oleh:

DUOPHARMA MANUFACTURING (BANGI) SDN BHD

Risalah maklumat

_ Consumer Medication Information Leaflet (RIMUP) _
1
BEATOLIN ELIXIR
Salbutamol sulphate ( 2mg/5ml)
WHAT IS IN THE LEAFLET?
1.
What BEATOLIN is used
for
2.
How BEATOLIN works
3.
Before
you
use
BEATOLIN
4.
How to use BEATOLIN
5.
While you are using it
6.
Side effects
7.
Storage
and
Disposal
of
BEATOLIN
8.
Product Description
9.
Manufacturer
and
Product
Registration Holder
10.
Date of Revision
WHAT BEATOLIN IS USED FOR
BEATOLIN Elixir helps you to
breathe
more
easily.
Because
the
medicine
in
your
Elixir
gives
relief
from
your
chest
symptoms, it is often called a
'reliever'.
HOW BEATOLIN WORKS
BEATOLIN Elixir belongs to a
group
of
medicines
called
bronchodilators.
BEATOLIN
Elixir works by opening up the
airways
tubes
in
your
lungs
when
your
chest
is
tight
or
when you are wheezing.
BEFORE YOU USE BEATOLIN
-
_When you must not use it_
•
if you have ever had an
allergic
reaction
to
salbutamol sulphate or any
of
the
ingredients
listed
toward
the
end
of
this
leaflet.
•
the
expiry
date
(EXP)
printed
on
the
pack
has
passed.
•
the
packaging
is
torn
or
shows signs of tampering
-
_Before you start to use it_
If you experience any of the
following,
please
tell
your
doctor before you start taking
BEATOLIN:
•
you are allergic to foods,
dyes, preservatives or any
other medicines.
•
you are taking any other
medicines,
including
medicines you buy without
a prescription.
•
you
have
had
to
stop
taking
this
or
any
other
asthma
medicine
for
any
reason.
•
you
have
high
thyroid
level.
•
you have a heart condition.
•
you have diabetes.
•
you
are
breastfeeding,
pregnant
or
trying
to
become pregnant.
-
_Taking other medicines_
Please
tell
your
doctor
or
pharmacist if you are taking or
have recently taken any other
medicines, including medicines
obtained without a prescription.
Caution
should
be
exercised
during
use
with
anaesthetic
agents
such
as
chloroform,
cyclopropane,
halothane
and
other halogenated agents.
The effects of this product may
be
altered
by
guanethidine,
reserpine, methyldopa, tricyclic
antidepressants.

Ciri produk

Glue
Glue
Pg15
Pg 14
Pg 13
Pg 12
Pg 11
Pg 10
Pg 9
Pg 1
Pg 3
Pg 2
Pg 4
Pg 5
Pg 6
Pg 7
Pg 8
IMMEDIATE LABEL
DESCRIPTION
A red, strawberry flavoured syrup.
_Each 5 ml contains:_
Salbutamol Sulphate equivalent to
Salbutamol 2 mg.
Preservative: Sodium Benzoate 0.1% w/v
Route of Administration : Oral
INDICATIONS
Salbutamol is indicated for the symptomatic
treatment
of
bronchial
asthma.
It
is
also
indicated
for
the
treatment
of
reversible
airways obstruction associated with bronchitis,
pulmonary emphysema, bronchiectasis and
other chronic obstructive pulmonary diseases.
PHARMACODYNAMICS
Salbutamol is a sympathomimetic agent
which
mimics
the
actions
produced
by
stimulation
of
postganglionic
sympathetic
or
adrenergic
nerves,
including stimulation of the heart and
central nervous system, vasoconstriction
of
blood
vessels
supplying
skin
and
mucous membranes, dilatation of the
bronchi and of blood vessels supplying
skeletal
muscle,
and
modulation
of
metabolism.
Salbutamol
is
a
beta-2
receptor
agonist.
Its
bronchodilator
effect is due to stimulation of beta-2
receptors in the lungs to relax bronchial
smooth
muscle,
thereby
relieving
bronchospasm, increasing vital capacity,
decreasing
residual
volume,
and
reducing airway resistance. This action
is
believed
to
result
from
increased
production
of
cyclic
adenosine
3',
5'-monophosphate (cAMP) caused by
activation of the enzyme adenyl
cyclase, the enzyme that catalyses the
effects.
Unwanted
effects
such
as
nervousness,
irritability,
insomnia
or
possibly
convulsions
or
cardiac
arrhythmias may result with the use
of
salbutamol
and
CNS
stimulants.
Hypokalaemia
associated
with
high
doses
of
salbutamol
may
result
in
increased
susceptibility
to
digitalis-induced
cardiac
arrhythmias.
Caution and close electrocardiographic
monitoring
are
very
important
if
concurrent use is necessary. Possibility
of cardiac arrhythmias is also increased
with
use
of
levodopa
concomitantly.
Hypokalaemia
may
be
enhanced
by
concomitant
administration
of
aminophylline
or
other
xanthines,
corticosteroids,
or
diur